GPT Analysis

Empower Your Investments! Unleash the Potential with Smart Stock Analysis!

United States Hong Kong China Singapore Japan India
Sorting Arrows
Symbol
▲ ▼
Company Name Rating
▲ ▼
Recommendation
▲ ▼
Evaluation from GPT Action Time
▲ ▼
INZY Inozyme Pharma Inc 70 Negative Inozyme Pharma Inc (INZY) is a pharmaceutical company in the USD market. The stock has seen a fluctuating performance in recent months, with a year high of $7.33 and a year low of $0.99. Its current market cap is $228.5 million. The fifty-day average is $3.54, and the two-hundred-day average is $4.62. This indicates a downward trend in the stock price over a longer term. INZY has a year change of 1.61, which shows some growth compared to the previous year. The stock's day high is $3.95, and the day low is $3.63. INZY has a good trading volume, with an average volume of 547,835 over the past three months. Overall, the stock performance of INZY has been inconsistent, and it is currently undervalued.

2023-11-23 13:11:40
JNPR Juniper Networks Inc 70 Positive Juniper Networks, Inc. (JNPR) is a technology company operating in the Communication Equipment industry. With a market capitalization of $9.07 billion, JNPR designs and sells networking products and services. The company has a strong presence in the Technology sector and employs approximately 10,901 full-time employees. JNPR's financial indicators show a trailing P/E ratio of 22.40 and a forward P/E ratio of 12.01, indicating a relatively lower valuation compared to its industry peers. The company has a dividend yield of 3.09% and a payout ratio of 68.25%. JNPR's financial performance has been impacted by a decline in earnings and revenue growth. However, the company has a solid balance sheet with a healthy cash position and manageable debt levels. Considering these factors, JNPR could be a suitable investment option for investors seeking exposure to the Communication Equipment industry.

2023-09-21 00:11:05
KGC Kinross Gold Corp 70 Positive Kinross Gold Corporation (KGC) is a gold mining company operating in the Basic Materials sector. The company has a market capitalization of $5.78 billion and operates primarily in Canada. KGC has a trailing price-to-earnings ratio (P/E) of 29.44 and a forward P/E of 13.08, indicating a relatively high valuation compared to its earnings. The company has a dividend yield of 2.6% and a payout ratio of 75%. KGC has shown a positive revenue growth of 33% and has a gross margin of 47.4%. However, it has a high debt-to-equity ratio of 41.25, which could pose a risk. Overall, KGC has a positive sentiment and a rating of 70, indicating a relatively good investment opportunity in the gold sector.

2023-08-22 13:19:32
LAC Lithium Americas Corp 70 Positive Lithium Americas Corp. (LAC) is a company in the Basic Materials sector, specifically in the Other Industrial Metals & Mining industry. LAC has 749 full-time employees and operates in Canada. The company has a market capitalization of $3.06 billion. LAC's stock price has a 52-week range of $16.07 to $32.17. The stock is currently trading at $19.14. LAC has a beta of 1.58369, indicating higher volatility compared to the market. The company's financial indicators show negative net income and earnings per share. LAC has a forward price-to-earnings ratio of 17.24, suggesting a moderate valuation. The company does not pay dividends. Analysts have a mean target price of $33.98 for LAC, indicating potential upside. Overall, the sentiment towards LAC is positive, and the stock is rated with a score of 70 out of 100.

2023-09-12 10:44:27
MRNA Moderna Inc 70 Positive Moderna, Inc. (MRNA) is a biotechnology company in the healthcare sector. With a market capitalization of $43.6 billion, Moderna focuses on developing mRNA-based vaccines and therapeutics. The company has 3,900 full-time employees and operates in the United States. Moderna's stock price has shown volatility, with a 52-week range of $95.02 to $217.25. The trailing P/E ratio is 39.24, indicating a relatively high valuation. However, the forward P/E ratio is negative, suggesting potential future earnings growth. Moderna has a strong balance sheet with $8.46 billion in total cash and $1.17 billion in total debt. The company's revenue growth has been negative, but it has gross margins of 16.92%. Overall, Moderna's stock has potential for growth, but investors should carefully consider the risks associated with the biotechnology industry.

2023-09-17 06:38:04
QYLD Global X NASDAQ 100 Covered Call ETF 70 Positive The Global X NASDAQ 100 Covered Call ETF (QYLD) is an exchange-traded fund that aims to provide investors with income and capital appreciation by investing in a portfolio of stocks from the NASDAQ 100 Index and selling covered call options on those stocks. QYLD has a trailing PE ratio of 27.58, indicating that the fund is relatively expensive compared to its earnings. The fund has a yield of 9.84%, which is attractive for income-seeking investors. QYLD has a three-year average return of 3.94% and a five-year average return of 3.71%, which are relatively low compared to the broader market. The fund has a beta of 0.7, indicating that it is less volatile than the overall market. Overall, QYLD can be considered as a moderate-risk investment option with a focus on generating income through covered call options.

2023-10-02 09:05:06
SE Sea Ltd 70 Positive Sea Limited (SE) is a Singapore-based internet retail company operating in the consumer cyclical sector. The company has a strong presence in Southeast Asia and has shown significant growth in recent years. However, it is important to note that SE has negative profit margins and a trailing EPS of -1.76. The company's financials indicate a high debt-to-equity ratio of 72.966, which could be a cause for concern. Despite these challenges, SE has a positive revenue growth rate of 4.9% and a gross margin of 43.14%. The stock has a target mean price of 88.69, suggesting potential upside. Considering the company's growth potential and market presence, it may be worth considering as an investment option.

2023-08-17 01:04:00
SPYD SPDR Portfolio S&P 500 High Dividend ETF 70 Positive SPYD is an exchange-traded fund (ETF) that tracks the performance of the S&P 500 High Dividend Index. It aims to provide exposure to high dividend yielding companies within the S&P 500 index. The fund has a trailing price-to-earnings ratio (P/E) of 13.32, indicating that the fund's holdings are relatively undervalued compared to the overall market. SPYD has a yield of 0.0477, which suggests a decent dividend income for investors. The fund has a three-year average return of 13.84% and a five-year average return of 3.51%. However, the year-to-date return is negative at -8.23%, which indicates a recent decline in performance. Overall, SPYD can be considered as a potential investment option for investors seeking exposure to high dividend yielding companies in the S&P 500 index.

2023-10-02 09:04:47
TIGR UP Fintech Holding Ltd 70 Positive UP Fintech Holding Limited (TIGR) is a Chinese company operating in the capital markets sector. TIGR has a market capitalization of $793.53 million and a trailing P/E ratio of 32.0, indicating that the stock may be slightly overvalued. The company has shown a positive revenue growth of 11.4% and has a gross margin of 81.9%. TIGR has a return on equity of 5.67% and a return on assets of 0.71%, which are relatively low compared to industry peers. The company has a strong cash position with total cash of $1.89 billion and no debt. TIGR has a target mean price of $5.60, suggesting a potential upside of 9.38% from the current price. Overall, TIGR shows potential for growth, but investors should carefully consider the risks associated with investing in a Chinese company and the volatility of the capital markets sector.

2023-10-02 08:50:30
TSLY YieldMax TSLA Option Income Strategy ETF 70 Positive TSLY, or the YieldMax TSLA Option Income Strategy ETF, is an exchange-traded fund that aims to generate income by selling covered call options on shares of Tesla (TSLA). The fund has a relatively low expense ratio and offers exposure to the potential upside of TSLA while generating income from the options premiums. TSLY has a 52-week range of $12.53 to $21.763, and its current price is $13.49. The fund has seen a positive year-to-date return of 49.87%. However, it is important to note that TSLY is a niche ETF focused on a specific strategy, and its performance is closely tied to the performance of TSLA. Investors should carefully consider their risk tolerance and investment objectives before investing in TSLY.

2023-10-02 08:41:51
AAIN Arlington Asset Investment Corp 70 Positive Arlington Asset Investment Corp (AAIN) is a financial services company that specializes in mortgage-related investments. The company operates as a real estate investment trust (REIT) and primarily invests in residential mortgage-backed securities (RMBS) and mortgage servicing rights (MSRs). AAIN's stock price has been relatively stable, with a 52-week range of $20.99 to $23.9. The stock is currently trading near its 52-week high, indicating positive investor sentiment. However, the average daily volume of 931 shares is relatively low, suggesting limited liquidity. AAIN's financial performance should be evaluated in the context of the broader mortgage market and interest rate environment. Given the company's focus on mortgage-related investments, factors such as changes in interest rates and housing market conditions can significantly impact its profitability. Investors should carefully consider their risk tolerance and conduct thorough research before investing in AAIN.

2023-10-04 14:14:42
ABCL AbCellera Biologics Inc 70 Positive AbCellera Biologics Inc. (ABCL) is a biotechnology company operating in the healthcare sector. The company specializes in the discovery and development of therapeutic antibodies. ABCL has a market capitalization of $1.45 billion and operates with 590 full-time employees. The stock has a beta of 0.0124, indicating low volatility compared to the overall market. ABCL's financial indicators show negative profit margins and earnings per share, which could be a concern for investors. However, the company has a strong cash position with $795.7 million in total cash and no debt. ABCL's revenue growth has been negative, but it is important to note that the biotechnology industry is highly research-intensive and often experiences fluctuations in financial performance. Analysts have a positive outlook on ABCL, with a mean target price of $24.43, suggesting potential upside. Considering the company's strong cash position and positive analyst sentiment, ABCL could be worth considering for long-term investors.

2023-09-25 04:48:52
AFB AllianceBernstein National Municipal Income Fund Inc 70 Positive AllianceBernstein National Municipal Income Fund, Inc. (AFB) is an asset management company operating in the financial services sector. The company has a market capitalization of $272,789,088 and offers a dividend yield of 4.14%. AFB has a beta of 0.41, indicating lower volatility compared to the overall market. The stock has a 52-week range of $9.23 to $11.46. AFB has a negative profit margin of -12.54% and a return on assets of 2.09%. The company's revenue growth has been negative at -2.7%. However, AFB has a strong current ratio of 7.99, indicating its ability to meet short-term obligations. Overall, AFB is a stable asset management company with a decent dividend yield and lower volatility. It may be suitable for income-focused investors seeking stability in the financial services sector.

2023-10-13 02:19:56
COF Capital One Financial Corp 70 Positive Capital One Financial Corporation (COF) is a credit services company operating in the financial services sector. With a market capitalization of $39.8 billion, COF has a strong presence in the United States with over 55,600 full-time employees. The company has a trailing P/E ratio of 7.96 and a forward P/E ratio of 7.75, indicating that the stock may be undervalued. COF has a dividend yield of 2.35% and a payout ratio of 18.28%, making it an attractive option for income investors. However, COF has experienced negative earnings growth and revenue growth in recent quarters, which may be a cause for concern. Overall, COF is a solid company with a strong market position, but investors should carefully consider the potential risks and rewards before making an investment decision.

2023-09-16 07:44:52
IMAX Imax Corp 70 Positive IMAX Corporation (IMAX) is a Canadian entertainment company operating in the communication services sector. With a market capitalization of $991 million, IMAX specializes in immersive cinematic experiences. The company has a strong presence in the entertainment industry, offering its proprietary IMAX technology to theaters worldwide. IMAX has a trailing PE ratio of 226.88 and a forward PE ratio of 17.62, indicating potential growth. The company's revenue growth rate stands at 32.5%, and it has a gross margin of 53.89%. IMAX has a solid balance sheet with a current ratio of 3.12 and a quick ratio of 2.72, indicating its ability to meet short-term obligations. However, IMAX carries a high debt-to-equity ratio of 80.07, which could be a concern. Overall, IMAX shows promise for investors interested in the entertainment sector, but careful consideration of its debt levels is advised.

2023-09-13 20:33:36
INZY Inozyme Pharma Inc 70 Negative Inozyme Pharma Inc (INZY) is a pharmaceutical company in the USD market. The stock has seen a fluctuating performance in recent months, with a year high of $7.33 and a year low of $0.99. Its current market cap is $228.5 million. The fifty-day average is $3.54, and the two-hundred-day average is $4.62. This indicates a downward trend in the stock price over a longer term. INZY has a year change of 1.61, which shows some growth compared to the previous year. The stock's day high is $3.95, and the day low is $3.63. INZY has a good trading volume, with an average volume of 547,835 over the past three months. Overall, the stock performance of INZY has been inconsistent, and it is currently undervalued.

2023-11-23 13:11:40
JNPR Juniper Networks Inc 70 Positive Juniper Networks, Inc. (JNPR) is a technology company operating in the Communication Equipment industry. With a market capitalization of $9.07 billion, JNPR designs and sells networking products and services. The company has a strong presence in the Technology sector and employs approximately 10,901 full-time employees. JNPR's financial indicators show a trailing P/E ratio of 22.40 and a forward P/E ratio of 12.01, indicating a relatively lower valuation compared to its industry peers. The company has a dividend yield of 3.09% and a payout ratio of 68.25%. JNPR's financial performance has been impacted by a decline in earnings and revenue growth. However, the company has a solid balance sheet with a healthy cash position and manageable debt levels. Considering these factors, JNPR could be a suitable investment option for investors seeking exposure to the Communication Equipment industry.

2023-09-21 00:11:05
KGC Kinross Gold Corp 70 Positive Kinross Gold Corporation (KGC) is a gold mining company operating in the Basic Materials sector. The company has a market capitalization of $5.78 billion and operates primarily in Canada. KGC has a trailing price-to-earnings ratio (P/E) of 29.44 and a forward P/E of 13.08, indicating a relatively high valuation compared to its earnings. The company has a dividend yield of 2.6% and a payout ratio of 75%. KGC has shown a positive revenue growth of 33% and has a gross margin of 47.4%. However, it has a high debt-to-equity ratio of 41.25, which could pose a risk. Overall, KGC has a positive sentiment and a rating of 70, indicating a relatively good investment opportunity in the gold sector.

2023-08-22 13:19:32
LAC Lithium Americas Corp 70 Positive Lithium Americas Corp. (LAC) is a company in the Basic Materials sector, specifically in the Other Industrial Metals & Mining industry. LAC has 749 full-time employees and operates in Canada. The company has a market capitalization of $3.06 billion. LAC's stock price has a 52-week range of $16.07 to $32.17. The stock is currently trading at $19.14. LAC has a beta of 1.58369, indicating higher volatility compared to the market. The company's financial indicators show negative net income and earnings per share. LAC has a forward price-to-earnings ratio of 17.24, suggesting a moderate valuation. The company does not pay dividends. Analysts have a mean target price of $33.98 for LAC, indicating potential upside. Overall, the sentiment towards LAC is positive, and the stock is rated with a score of 70 out of 100.

2023-09-12 10:44:27
MRNA Moderna Inc 70 Positive Moderna, Inc. (MRNA) is a biotechnology company in the healthcare sector. With a market capitalization of $43.6 billion, Moderna focuses on developing mRNA-based vaccines and therapeutics. The company has 3,900 full-time employees and operates in the United States. Moderna's stock price has shown volatility, with a 52-week range of $95.02 to $217.25. The trailing P/E ratio is 39.24, indicating a relatively high valuation. However, the forward P/E ratio is negative, suggesting potential future earnings growth. Moderna has a strong balance sheet with $8.46 billion in total cash and $1.17 billion in total debt. The company's revenue growth has been negative, but it has gross margins of 16.92%. Overall, Moderna's stock has potential for growth, but investors should carefully consider the risks associated with the biotechnology industry.

2023-09-17 06:38:04